the public private mix program and … public private mix program and ... providers are permitted to...

1
THE PUBLIC PRIVATE MIX PROGRAM AND ANTIMALARIAL AND MALARIA RAPID DIAGNOSTIC TEST AVAILABILITY AND MARKET SHARE IN THE SOUTHERN LAO PDR PRIVATE SECTOR Keith Esch* 1 , Saysana Phanalasy 2 , Sengkeo Vongviengxay1 2 , ACTwatch Group *1 1 PSI; 2 PSI/Laos BACKGROUND In 2008, a Public Private Mix (PPM) program was initiated in southern Lao PDR to increase the availability of the first-line artemisinin combination therapy (ACT), artemether lumefantrine (AL), and malaria rapid diagnostic tests (mRDTs) in the private sector at little to no cost to the consumer. AL and mRDTs are provided free of charge from the Center for Malaria Parasitology and Entomology (CMPE). Providers are permitted to sell AL for approximately USD $0.12 and mRDT services for USD $0.25. Providers receive training on malaria case management and are expected to report data to the nearest health center or district antimalarial nucleus (DAMN). METHODS A 2015 malaria outlet survey was conducted in 25 PPM districts and 16 non-PPM districts across five southern provinces (Savannakhet, Champasack, Salavanh, Attapeu and Sekong). Approximately 95% of the country’s total malaria burden is concentrated in these five provinces. All outlets with the potential to sell antimalarials were screened for study eligibility among 41 of 42 districts (Figure 1). This included pharmacies and private for-profit facilities in PPM (N=351) and non-PPM districts (N=300). In the antimalarial stocking facilities, an audit was completed for all antimalarials and mRDTs. Data were retroactively analyzed to present indicators on availability, market share and provider knowledge among outlets located in the PPM and non-PPM districts. RESULTS How does the availability of appropriate malaria case management commodities compare across PPM versus non-PPM districts? First-line ACT (AL) were available in 68.5% of antimalarial- stocking PPM district pharmacies and private for-profit facilities versus 2.5% in non-PPM districts. First- line ACT was free in all AL-stocking outlets in both PPM and non-PPM districts (data not shown). Availability of mRDT was high in PPM (72.6%) district pharmacies and private for-profit facilities compared with 12.1% in non-PPM districts (Figure 2). The median price for mRDT in PPM district antimalarial-stocking outlets was USD $0.00 compared with USD $3.12 in non-PPM districts (data not shown). Was chloroquine (CQ) widely available in both PPM and non-PPM district antimalarial-stocking outlets? CQ was widely available across the private sector regardless of PPM status. Nearly two- thirds (63.7%) of antimalarial-stocking private sector outlets in PPM districts stocked CQ. Almost all (96.7%) antimalarial-stocking private sector outlets in non-PPM districts stocked CQ (Figure 2). What are the most commonly distributed antimalarials in the PPM districts versus non-PPM districts? Higher availability of AL in private sector antimalarial-stocking PPM district outlets did not translate into higher AL market share. AL market share was low regardless of PPM status. The majority of anti-malarials distributed by pharmacies and private for-profit health facilities were CQ treatments in both PPM (61.7%) and non-PPM districts (99.1%) (Figure 3). Was provider knowledge higher in PPM district antimalarial-stocking outlets than non-PPM antimalarial-stocking outlets? Provider knowledge, with regards to correctly stating the first-line treatment for uncomplicated P. falciparum (Pf) P. Vivax (Pv) was higher in private sector outlets in PPM districts (65.0%) than non-PPM districts (15.0%). In PPM districts, 51.0% of providers correctly stated the first-line dosing regimens for uncomplicated Pf /Pv compared with only 6.1% of providers in private sector non-PPM district outlets (Figure 4). ASTMH, 65 th Annual Meeting, Atlanta, Nov 2016 * ACTwatch is a Population Services International (PSI) research project implemented in partnership with the London School of Tropical Medicine and Hygiene and Ministries of Health in project countries. ACTwatch is funded by the Bill and Melinda Gates Foundation, DFID and UNITAID. Poster contents do not necessarily reflect the views of the funders. For more information please visit www.actwatch.info or contact Megan Littrell at [email protected] . CONCLUSION Access to first-line ACT and mRDT was higher in PPM district antimalarial- stocking private sector outlets compared with non-PPM outlets. However, CQ availability and distribution was high in both PPM and non-PPM districts. Expansion of the PPM program could increase availability of mRDT and ACT, as well as improve provider treatment and dosing knowledge, all of which are paramount in the context of national malaria elimination goals in Lao PDR. However, interventions aimed at provider preference and consumer demand may also be necessary to reduce CQ availability and market share in the private sector. Figure 3: Antimalarial market share within antimalarial-stocking private sector outlets in PPM versus non-PPM districts Figure 4: Provider knowledge of national first-line treatment and dosing regimen for uncomplicated Pf/Pv malaria within pharmacies and private for-profit health facilities in PPM versus non-PPM districts Figure 2: Availability of AL, mRDT and Chloroquine (CQ) across in antimalarial-stocking private sector outlets in PPM versus non-PPM Figure 1: PPM and non- PPM districts selected in Lao PDR’s southern five provinces (Savannakhet, Champasack, Salavanh, Attapeu and Sekong) LB-5266 0 10 20 30 40 50 60 70 80 90 100 AL mRDT CQ PERCENT OF OUTLETS PPM Districts Non-PPM Districts PPM N=264 Non- PPM N=101 PPM N=264 Non- PPM N=265 PPM N=264 Non- PPM N=101 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% PPM Districts Non-PPM Districts MARKET SHARE CQ AL 0 10 20 30 40 50 60 70 80 90 100 Correctly state the national first-line treatment for uncomplicated Pf/Pv malaria Correctly state the first-line dosing regimen for uncomplicated Pf/Pv malaria PERCENT OF OUTLETS PPM N=275 Non- PPM N=110 PPM N=275 Non- PPM N=110

Upload: truongkhuong

Post on 09-May-2018

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: THE PUBLIC PRIVATE MIX PROGRAM AND … PUBLIC PRIVATE MIX PROGRAM AND ... Providers are permitted to sell AL for approximately USD $0.12 and mRDT services for USD ... Provider knowledge,

THE PUBLIC PRIVATE MIX PROGRAM AND ANTIMALARIAL AND MALARIA RAPID DIAGNOSTIC TEST AVAILABILITY AND MARKET SHARE IN THE SOUTHERN LAO PDR PRIVATE SECTOR

Keith Esch*1, Saysana Phanalasy2, Sengkeo Vongviengxay12, ACTwatch Group*1

1PSI; 2 PSI/Laos

BACKGROUND

In 2008, a Public Private Mix (PPM) program was initiated in southern Lao PDR to increase the

availability of the first-line artemisinin combination therapy (ACT), artemether lumefantrine (AL), and

malaria rapid diagnostic tests (mRDTs) in the private sector at little to no cost to the consumer. AL and

mRDTs are provided free of charge from the Center for Malaria Parasitology and Entomology (CMPE).

Providers are permitted to sell AL for approximately USD $0.12 and mRDT services for USD $0.25.

Providers receive training on malaria case management and are expected to report data to the nearest

health center or district antimalarial nucleus (DAMN).

METHODS

A 2015 malaria outlet survey was conducted in 25 PPM districts and 16 non-PPM districts across five

southern provinces (Savannakhet, Champasack, Salavanh, Attapeu and Sekong). Approximately 95%

of the country’s total malaria burden is concentrated in these five provinces. All outlets with the potential

to sell antimalarials were screened for study eligibility among 41 of 42 districts (Figure 1). This included

pharmacies and private for-profit facilities in PPM (N=351) and non-PPM districts (N=300). In the

antimalarial stocking facilities, an audit was completed for all antimalarials and mRDTs. Data were

retroactively analyzed to present indicators on availability, market share and provider knowledge among

outlets located in the PPM and non-PPM districts.

RESULTS

How does the availability of appropriate malaria case management commodities compare

across PPM versus non-PPM districts? First-line ACT (AL) were available in 68.5% of antimalarial-

stocking PPM district pharmacies and private for-profit facilities versus 2.5% in non-PPM districts. First-

line ACT was free in all AL-stocking outlets in both PPM and non-PPM districts (data not shown).

Availability of mRDT was high in PPM (72.6%) district pharmacies and private for-profit facilities

compared with 12.1% in non-PPM districts (Figure 2). The median price for mRDT in PPM district

antimalarial-stocking outlets was USD $0.00 compared with USD $3.12 in non-PPM districts (data not

shown).

Was chloroquine (CQ) widely available in both PPM and non-PPM district antimalarial-stocking

outlets? CQ was widely available across the private sector regardless of PPM status. Nearly two-

thirds (63.7%) of antimalarial-stocking private sector outlets in PPM districts stocked CQ. Almost all

(96.7%) antimalarial-stocking private sector outlets in non-PPM districts stocked CQ (Figure 2).

What are the most commonly distributed antimalarials in the PPM districts versus non-PPM

districts? Higher availability of AL in private sector antimalarial-stocking PPM district outlets did not

translate into higher AL market share. AL market share was low regardless of PPM status. The

majority of anti-malarials distributed by pharmacies and private for-profit health facilities were CQ

treatments in both PPM (61.7%) and non-PPM districts (99.1%) (Figure 3).

Was provider knowledge higher in PPM district antimalarial-stocking outlets than non-PPM

antimalarial-stocking outlets? Provider knowledge, with regards to correctly stating the first-line

treatment for uncomplicated P. falciparum (Pf) P. Vivax (Pv) was higher in private sector outlets in PPM

districts (65.0%) than non-PPM districts (15.0%). In PPM districts, 51.0% of providers correctly stated

the first-line dosing regimens for uncomplicated Pf /Pv compared with only 6.1% of providers in private

sector non-PPM district outlets (Figure 4).

ASTMH, 65th Annual Meeting, Atlanta, Nov 2016

* ACTwatch is a Population Services International (PSI) research project implemented in partnership with the London School of Tropical Medicine and Hygiene and Ministries of

Health in project countries. ACTwatch is funded by the Bill and Melinda Gates Foundation, DFID and UNITAID. Poster contents do not necessarily reflect the views of the funders.

For more information please visit www.actwatch.info or contact Megan Littrell at [email protected].

CONCLUSION

Access to first-line ACT and mRDT was higher in PPM district antimalarial-

stocking private sector outlets compared with non-PPM outlets. However, CQ

availability and distribution was high in both PPM and non-PPM districts.

Expansion of the PPM program could increase availability of mRDT and ACT,

as well as improve provider treatment and dosing knowledge, all of which are

paramount in the context of national malaria elimination goals in Lao PDR.

However, interventions aimed at provider preference and consumer demand

may also be necessary to reduce CQ availability and market share in the

private sector.

Figure 3: Antimalarial market share within antimalarial-stocking private sector outlets in PPM

versus non-PPM districts

Figure 4: Provider knowledge of national first-line treatment and dosing regimen for uncomplicated

Pf/Pv malaria within pharmacies and private for-profit health facilities in PPM versus non-PPM

districts

Figure 2: Availability of AL, mRDT and Chloroquine (CQ) across in antimalarial-stocking private sector

outlets in PPM versus non-PPM

Figure 1: PPM and non-

PPM districts selected in

Lao PDR’s southern five

provinces (Savannakhet,

Champasack, Salavanh,

Attapeu and Sekong)

LB-5266

0

10

20

30

40

50

60

70

80

90

100

AL mRDT CQ

PE

RC

EN

T O

F O

UT

LE

TS

PPM Districts Non-PPM Districts

PPMN=264

Non- PPMN=101

PPMN=264

Non- PPMN=265

PPMN=264

Non- PPMN=101

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

PPM Districts Non-PPM Districts

MA

RK

ET

SH

AR

E

CQ AL

0

10

20

30

40

50

60

70

80

90

100

Correctly state the national first-line treatment foruncomplicated Pf/Pv malaria

Correctly state the first-line dosing regimen foruncomplicated Pf/Pv malaria

PE

RC

EN

T O

F O

UT

LE

TS

PPM Districts Non-PPM Districts

PPMN=275

Non- PPMN=110

PPMN=275

Non- PPMN=110